Company Filing History:
1 out of 15 
1 out of 1 Years Active: 2007
Title: The Innovations of Charles Cunningham
Introduction
Charles Cunningham is a notable inventor based in Bergen, GB. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for both human and animal health, showcasing the versatility and importance of his inventions.
Latest Patents
Cunningham holds a patent for a monoclonal antibody known as 3F1H10, which neutralizes the viral hemorrhagic septicemia virus (VHSV). This invention relates to a non-infectious nucleic acid construct designed to express a recombinant antibody or antibody fragment in a host cell. The antibody molecule provides protection to the host against various pathogens, allergens, or toxins, and can be utilized in any animal, including humans and fish.
Career Highlights
Throughout his career, Cunningham has worked with esteemed institutions such as Aberdeen University and Dianova. His research has focused on developing innovative solutions to combat viral infections, demonstrating his commitment to advancing medical science.
Collaborations
Cunningham has collaborated with notable colleagues, including Christopher John Secombes and Niels Lorenzen. These partnerships have contributed to the success of his research and the development of his patented technologies.
Conclusion
Charles Cunningham's work in the field of monoclonal antibodies represents a significant advancement in biotechnology. His inventions have the potential to improve health outcomes for both humans and animals, highlighting the importance of innovation in addressing global health challenges.